0.10 (2.62%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Neutral
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Neutral
Earnings
Neutral
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Strong
Balance Sheet
Very Weak
Website
Medexus Pharmaceuticals Inc.
Telephone
1.437.836.1070
Address
Suite 600, 10 Kings Street East, Toronto, ON M5C 1C3
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 2.47 - 4.16
Trade Value (12mth)
US$25,466.00
1 week
-2.24%
1 month
1.03%
YTD
26.86%
1 year
44.12%
All time high
11.25
EPS 3 yr Growth
30.80%
EBITDA Margin
18.60%
Operating Cashflow
$24m
Free Cash Flow Return
0.00%
ROIC
0.00%
Interest Coverage
2.50
Quick Ratio
0.00
Shares Outstanding (Fully Diluted)
32m
HALO Sector
Healthcare
Next Company Report Date
30-Jun-26
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -0.01 | 0.09 | 0.08 | | | | ||
EPS (Fully Diluted) | $ | | | | | -0.01 | 0.08 | N/A | | | | ||
Growth | % | | | | | -115.6 | 1,009.7 | -8 | | | | ||
PE | X | | | | | N/A | 20 | N/A | | | | ||
EV/EBITDA | X | | | | | 3.8 | 3.3 | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
